# US 6,729,265 B2 · Supplemented antibody feed to enter the circulating system of newborns

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,729,265 B2
- Document ID: US6729265B2
- Status: Granted
- Kind: B2
- Application number: 10/185,590
- Filed: 2002-06-27
- Published: 2004-01-01
- Granted: 2004-05-04
- Earliest claimed: 2002-06-27
- Assignees: Arkion Life Sciences, LLC
- Inventors: Leslie A. Confer; Jeffrey G. Hunchar; Kevin C. Somerville
- Web page: https://patentgrep.com/patent/US6729265B2

## CPC

- A01K 45/00: Other aviculture appliances, e.g. devices for determining whether a bird is about to lay
- A01K 39/00: Feeding or drinking appliances for poultry or other birds
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

A method for supplementing new antibody or adding additional titer of an already present antibody into the circulating system in a newborn by feeding antibody to the newborn within the first few days of its life. The antibody is preferably obtained from the egg of an immunized mother and fed to the newborn within the first 24 hours of its life.

## Claims

### Claim 1

A method for generating systemic immunity in a hatchling, the method comprising orally administering a composition comprising a dried egg product to said hatchling within the first 24 hour period after the hatchling is hatched, wherein the egg product is obtained from an egg-producing animal that has been hyperimmunized with an immunogenic vaccine comprising immunogens that do not cause avian gastrointestinal disease.

### Claim 2 (depends on 1)

The method of claim 1, wherein the antibody is not present in the circulating system of the hatchling prior to the feeding of the egg product.

### Claim 3 (depends on 1)

The method of claim 1 wherein the immunogenic vaccine comprises at least one antigen selected from the group consisting of bacterial, viral, protozoan, fungal, and cellular antibodies and mixtures thereof.

### Claim 4 (depends on 1)

The method of claim 1 wherein the egg product comprises an effective concentration of IgY.

### Claim 5 (depends on 1)

The method of claim 1 wherein the hatching is selected from the group consisting of avians, reptiles, fish and amphibians.

### Claim 6

A method for increasing the titer of an antibody in the circulating system of a hatchling, the method comprising orally administering a composition comprising a dried egg product to said hatching within the first 24 hour period after the hatching is hatched, wherein the egg product is obtained from an egg-producing animal that has been hyperimmunized with an immunogenic vaccine comprising immunogens that do not cause avian gastrointestinal disease.

### Claim 7 (depends on 6)

The method of claim 6 wherein the immunogenic vaccine comprises at least one antigen selected from the group consisting of bacterial, viral, protozoan, fungal, and cellular antibodies and mixtures thereof.

### Claim 8 (depends on 6)

The method of claim 6 wherein the egg product comprises an effective concentration of IgY.

### Claim 9 (depends on 6)

The method of claim 6 wherein the hatching is selected from the group consisting of avians, reptiles, fish and amphibians.

### Claim 10

A method for supplementing an antibody into the circulating system of a hatching, the method comprising orally administering a composition comprising a dried egg product to said hatchling within the first 24 hour period after the hatchling is hatched, wherein the egg product is obtained from an egg-producing animal that has been hyperimmunized with an immunogenic vaccine comprising immunogens that do not cause avian gastrointestinal disease.

### Claim 11 (depends on 10)

The method of claim 10 wherein the antibody is not present in the circulating system of the hatchling prior to the feeding of the egg product.

### Claim 12 (depends on 10)

The method of claim 10 wherein the immunogenic vaccine comprises at least one antigen selected from the group consisting of bacterial, viral, protozoan, fungal, and cellular antibodies and mixtures thereof.

### Claim 13 (depends on 10)

The method of claim 10 wherein the egg product comprises an effective concentration of IgY.

### Claim 14 (depends on 10)

The method of claim 10 wherein the hatchling is selected from the group consisting of avians, reptiles, fish and amphibians.
